Company overview
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing IMA with another company.
| Daily close (USD) | $4.26 |
| Market capitalization (USD) | $48,357,202.56 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.34 |
No matching rows. Clear the filter to see all records.
Read IMA's valuation metrics
Company size
ImageneBio, Inc. Common Stock's recorded market capitalization is $48,357,202.56. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
IMA's recorded price-to-book ratio is 0.34. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research ImageneBio, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about IMA. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow IMA's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.